Depression/Antidepressant Use Associated With QOL but not OS in Patients With Hematologic Malignancies Undergoing HSCT, Study Finds
This study separately evaluated the impact of depression/antidepressant use on the QOL and OS of cohorts of patients undergoing allogeneic or autologous HSCT.